QSC Tirzepatide 99% White Powder - High Purity Weight Loss Peptide Supplier

QSC Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. This innovative compound demonstrates superior efficacy in both glucose regulation and weight management compared to selective GLP-1 receptor agonists.

The QSC Tirzepatide formulation exhibits preferential binding affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual mechanism of action has shown promising results in metabolic research, particularly in studies investigating hyperglycemia reduction and weight management protocols.

Our pharmaceutical grade QSC Tirzepatide is supplied as a white lyophilized powder with purity exceeding 99% by HPLC analysis. The material is carefully packaged to ensure stability and is suitable for various research formulations. Each batch undergoes rigorous quality control testing to guarantee consistent performance in experimental applications.

For research purposes only, QSC Tirzepatide represents a significant advancement in peptide-based metabolic research. Its dual agonist properties make it particularly valuable for comparative studies against single-receptor agonists and for investigating novel treatment approaches for metabolic disorders.